[Role of surgical therapy in the treatment of refractory ascites].
In 5-10% of cases ascites is not controlled by medical therapy and is defined refractory. These patients may be submitted to one of the four following surgical options: portal-systemic shunt, peritoneo-venous shunt, transjugular intrahepatic portal-systemic shunt, orthotopic liver transplantation. Although the portal-systemic shunt is efficient in clearing ascites, it does not improve the survival, which depends on liver function, and it is complicated by an important incidence of encephalopathy. Since the patients with refractory ascites and good hepatic risk are not usually many, it is possible to understand why derivative surgery has been disappointing with this indication. Although the peritoneo-venous shunt is associated with a significant rate of valve obstruction, it is an easy, effective and not expensive treatment. So, till now, it has been considered the first choice procedure of refractory ascites, if any situations, determinating the onset of postoperative complications, are not present. Recently a new method has been introduced in the therapy of portal hypertension, the transjugular intrahepatic portal-systemic shunt. This is a bloodless portal-systemic derivation and so it has caused great enthusiasm even if the available data are insufficient to give a definitive opinion on its role in management of ascites. Certainly the liver transplantation, which presents the great advantage to treat both the cirrhosis and its complications, seems to be the most rational therapy for these patients. However, at least for this moment, the well-known absence of organ donors makes still actual the palliative surgical measures.
Pisani Ceretti
A
A
II Divisione di Chirurgia, Ospedale Fatebenefratelli e Oftalmico, Milano.
Intra
M
M
Borzio
M
M
Santambrogio
R
R
Opocher
E
E
Ballarini
C
C
Cordovana
A
A
Motta
R
R
Spina
G P
GP
D001201:Ascites / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D016031:Liver Transplantation; D010536:Peritoneovenous Shunt; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000401:mortality
Ruolo della terapia chirurgica nel trattamento dell'ascite refrattaria.